Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Weekly Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With SCCHN

NCT01437449 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01437449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01437449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Weekly Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With SCCHN
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2011
Completion date
August 31, 2019
Enrollment
27 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer